MAPT and early-onset autosomal dominant Alzheimer disease: Treatment with this nanocomplex-PROTAC significantly degraded hyperphosphorylated Tau protein in both cell cultures and the hippocampus and cerebral cortex of a transgenic mouse model of Alzheimer’s disease.